Screener Summaries Updates Institutions Sign In More Updates › Mergers & Acquisitions › INCR Mergers & Acquisitions · Jun 15, 2026
InterCure Ltd. announced on June 15, 2026, that it is initiating a strategic review of its medical cannabis… INCR Intercure Ltd.
InterCure Ltd. announced on June 15, 2026, that it is initiating a strategic review of its medical cannabis opportunities in the United States following federal rescheduling. Additionally, the company completed the initial closing of its acquisition of Botanico. InterCure Ltd. is a medical cannabis company.
More from Intercure Ltd. InterCure Ltd. regained compliance with Nasdaq's minimum bid price requirement following a delisting notice received… Sep 8, 2026 On August 12, 2026, InterCure Ltd. entered into a securities purchase agreement for a private placement offering of… Aug 26, 2026 InterCure finalized a settlement with Israeli authorities for NIS 230 million (approximately US$77 million) in… Aug 24, 2026 InterCure Ltd. has called an Extraordinary General Meeting of Shareholders for August 11, 2026, to vote on a proposed… Jul 27, 2026 InterCure Ltd. has announced an Extraordinary General Meeting of Shareholders on August 12, 2026, to vote on a… Jul 22, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
